Subscribe to RSS
DOI: 10.1055/s-2004-861527
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.
Josep O. Dalmau, M.D., Ph.D.
Publication History
Publication Date:
07 January 2005 (online)


Dr. Josep Dalmau is the Guest Editor of this issue of Seminars in Neurology on the Neurological Complications of Cancer. Dr. Dalmau is Associate Professor of Neurology at the University of Pennsylvania and is an Associate Investigator in the Abramson Comprehensive Cancer Research Institute in Philadelphia. He is the Director of the Neuro-Oncology Laboratory at the University of Pennsylvania.
Dr. Dalmau received his Bachelor of Science degree from Instituto Nacional de Ensenanza Media, Ausias March, Barcelona, Spain. He received his medical degree from Autonoma University of Barcelona, Spain, and then did an internship in Internal Medicine at University Hospital de la Sta. Cruz y San Pablo, Barcelona, Spain. He then served as a physician in the Spanish Army Service followed by a Residency in Neurology at the University Hospital de la Sta. Cruz y San Pablo, Barcelona, Spain. He served on the faculty of the University Hospital of Sabadell, Barcelona, Spain, and then became a Research Fellow in the Cotzias Laboratory of Neuro-Oncology at the Sloan-Kettering Institute in New York. This was followed by a Clinical Fellowship in Neurology at New York Hospital, Cornell University, and then a Fellowship in Neuro-Oncology at Memorial Hospital for Cancer and Allied Diseases in New York. During this time he was also working on a Ph.D. After obtaining his Ph.D., he held faculty positions at Memorial Hospital for Cancer and Allied Diseases and the University of Arkansas, prior to being recruited to the University of Pennsylvania to develop the Division of Neuro-Oncology.
Dr. Dalmau's clinical research is on the treatment of malignant brain tumors and the understanding of the paraneoplastic neurological disorders. His present focus is on autoantigen profiling in paraneoplastic disorders of the central nervous system and immunity to brain Ma proteins. He was the director of the Course on Neurologic Complications of Systemic Cancer at the American Academy of Neurology. He has been invited to present his work at the 7th International Congress of Neuroimmunology in Venice, Italy, at the World Congress of Neurology, at the Dresden Symposium, at the University of Athens, and in the Presidential Symposium of the American Neurological Association. He is a great scholar and has contributed significantly to the literature, including an article on paraneoplastic limbic and brain stem encephalitis in patients with testicular cancer that was published in the New England Journal of Medicine, an article on cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies that was published in the Annals of Neurology, and an article on Ma1, a novel neuronal and testis specific protein in the serum of patients with paraneoplastic neurological disorders, that was published in Brain. He has published articles on the clinical analysis of anti-Ma2-associated encephalitis, neuro-ophthalmology in paraneoplastic syndromes, clinical and immunological features of patients with anti-Tr antibodies, cerebellar degeneration and autoimmunity, paraneoplastic brain stem encephalitis and anti-Ri antibodies, and therapy of paraneoplastic syndromes. To do extensive research on all that is known about paraneoplastic syndromes, one only has to review Dr. Dalmau's publications. He has provided us with a thorough and extensive knowledge of these disorders.
Dr. Dalmau has made an incredible contribution to mankind through his life's work, and we are honored and delighted to welcome him as the Guest Editor of this issue of Seminars in Neurology.